HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity
- 30 October 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 105 (1), 193-200
- https://doi.org/10.1097/tp.0000000000003507
Abstract
Background: SARS-CoV-2 infection is heterogeneous in clinical presentation and disease evolution. To investigate whether immune response to the virus can be influenced by genetic factors, we compared HLA and AB0 frequencies in organ transplant recipients and waitlisted patients according to presence or absence of SARS-CoV-2 infection. Methods: A retrospective analysis was performed on an Italian cohort composed by transplanted and waitlisted patients in a January 2002-March 2020 time frame. Data from this cohort were merged with the Italian registry of COVID+ subjects, evaluating infection status of transplanted and waitlisted patients. A total of 56304 cases were studied with the aim of comparing HLA and AB0 frequencies according to the presence (n=265, COVID+) or absence (n=56 039, COVID-) of SARS-CoV-2 infection. Results: The cumulative incidence rate of COVID-19 was 0.112% in the Italian population and 0.462% in waitlisted/transplanted patients (OR=4.2, 95%CI [3.7-4.7], PHLA-DRB1*08 was more frequent in COVID+ (9.7% and 5.2%: OR=1.9, 95%CI [1.2-3.1]; P=0.003; Pc=0.036). In COVID+ patients, HLA-DRB1*08 was correlated to mortality (6.9% in living vs 17.5% in deceased: OR=2.9, 95%CI [1.15-7.21]; P=0.023). Peptide binding prediction analyses showed that these DRB1*08 alleles were unable to bind any of the viral peptides with high affinity. Lastly, blood group A was more frequent in COVID+ (45.5%) than COVID- patients (39.0%; OR=1.3, 95%CI [1.02-1.66]; P=0.03). Conclusions: Even though preliminary, these results suggest that HLA antigens may influence SARS-CoV-2 infection and clinical evolution of COVID-19 and confirm that blood group A individuals are at greater risk of infection, providing clues on the spread of the disease and indications about infection prognosis and vaccination strategies.Keywords
This publication has 31 references indexed in Scilit:
- Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virusVirologica Sinica, 2014
- Estimation of human leukocyte antigen class I and class II high-resolution allele and haplotype frequencies in the Italian population and comparison with other European populationsHuman Immunology, 2012
- Human-Leukocyte Antigen Class I Cw 1502 and Class II DR 0301 Genotypes Are Associated with Resistance to Severe Acute Respiratory Syndrome (SARS) InfectionViral Immunology, 2011
- Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese populationHuman Immunology, 2009
- HLA and Infectious DiseasesClinical Microbiology Reviews, 2009
- Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodiesGlycobiology, 2008
- Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applicationsImmunogenetics, 2005
- A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infectionBMC Infectious Diseases, 2004
- Association of HLA class I with severe acute respiratory syndrome coronavirus infectionBMC Medical Genetics, 2003
- Evolutionary relationships of HLA-DR8 alleles and description of a new subtype (DRB1∗0806) in the Algerian populationHuman Immunology, 1993